Frank X. Leonard - 08 Sep 2022 Form 4/A - Amendment Insider Report for NovoCure Ltd (NVCR)

Role
Chief Development Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Issuer symbol
NVCR
Transactions as of
08 Sep 2022
Net transactions value
-$550,316
Form type
4/A - Amendment
Filing time
13 Sep 2022, 16:15:30 UTC
Date Of Original Report
12 Sep 2022
Previous filing
07 Sep 2022
Next filing
12 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale $550,316 -6,754 -8% $81.48 77,396 08 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amending original Form 4 filed on September 12, 2022 to add additional transaction inadvertently omitted.
F2 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard.